
Sahajanand Medical Technologies
23 Oct '26MAINBOARD
Min. Investment
₹14,061
Issue size
₹475 Cr
GMP
Locked
Overall subscription: 0.07x
Expert verdict

IPO dates
15 Oct
Opening
19 Oct
Closing
23 Oct
Listing
IPO quota
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 43 | ₹14,792 |
| HNI (Min) | 14 | 602 | ₹2,07,088 |

Subscription (as on 15 October 2026, 12:00 PM)
Overall0.07x
About company
Founded: 1999|MD: Mr Bhargav Dhirajlal Kotadia
- Sahajanand Medical Technologies Limited develops, manufactures, and sells medical devices used in vascular and structural heart interventions. Founded in 2001, the company offers vascular intervention products, including coronary stents and coronary balloon catheters, and structural heart products, including transcatheter aortic valve implantation (TAVI) devices and occluders. Its portfolio also includes renal stents, peripheral drug-coated balloons, and traded medical products.
- The company markets its products through direct sales, hybrid, and distributor-led models. In FY26, it generated revenue from 77 countries, including India, with operations across Europe and other international markets. It currently operates three manufacturing facilities, two in India and one in Thailand. Additionally, it has two research and development centres, located in India and Thailand, focused on medical device development and product improvements.
- Use of proceeds:
- The IPO is an offer-for-sale (OFS). The company will not receive any proceeds from the offer. Net proceeds from the offer will go to the promoter selling shareholders in proportion to the number of shares offered by them for sale.
- The primary objective of the offer is to achieve the benefits of listing the equity shares on the stock exchanges, which is expected to enhance the company’s visibility and brand recognition. Listing will also provide liquidity to the existing shareholders and create a public market for the company’s shares in India.
Issue Details & Objective
Lot size
43 Shares
Price band
₹327 to 344
Face value
₹1 per share

Financials
FAQs
Our SEBI-registered investment advisors give out verdicts for each IPO. You can refer to their expert verdict at the top of this page. Please note that these verdicts are for informational purposes only and should not be construed as investment advice. Markets are subject to risk, and investors should exercise their own discretion and diligence.
The issue size of Sahajanand Medical Technologies IPO is ₹475 Cr
The Sahajanand Medical Technologies IPO will be open for applications from 15 Oct '26 to 19 Oct '26
The lot size of Sahajanand Medical Technologies IPO is 43 Shares and its minimum investment amount is ₹14,061.

